Literature DB >> 6121878

Biochemical and pharmacological activities of zetidoline (DL 308-IT): a new antidopaminergic agent.

D Barone, N Corsico, A Diena, A Restelli, A Glässer, F Rodenghi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6121878     DOI： 10.1111/j.2042-7158.1982.tb04205.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN： 0022-3573            Impact factor:   3.765


× No keyword cloud information.
  5 in total

1.  Structural requirements of Na+-dependent antidopaminergic agents: Tropapride, Piquindone, Zetidoline, and Metoclopramide. Comparison with Na+-independent ligands.

Authors:  S Collin; D P Vercauteren; D Vanderveken; G Evrard; F Durant
Journal:  J Comput Aided Mol Des       Date:  1989-03       Impact factor: 3.686

2.  Metabolic fate of zetidoline, a new neuroleptic agent, in man.

Authors:  A Assandri; A Perazzi; P Ferrari; E Martinelli; A Ripamonti; G Tarzia; G Tuan
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-01       Impact factor: 3.000

3.  Proceedings of the British Pharmacological Society. University of Leicester, 6th-8th July, 1983. Abstracts.

Authors: 
Journal:  Br J Pharmacol       Date:  1983-09       Impact factor: 8.739

4.  A comparison of some psychological and physiological effects exerted by zetidoline (DL308) and by oxazepam.

Authors:  M Herbert; P J Standen; A H Short; A T Birmingham
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

5.  Effects of acute administration of zetidoline, a new antidopaminergic drug, on plasma prolactin and aldosterone levels in man.

Authors:  C Barbieri; M Parodi; S Bruno; F Bertassi; D Benaglia; P Moser; R Meroni; A Dubini
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.